logo
Hong Kong's New Platform for $166 Billion Pension Faces Glitches

Hong Kong's New Platform for $166 Billion Pension Faces Glitches

Bloomberg06-06-2025
Some Hong Kong pensioners migrating to a new electronic system for retirement savings have experienced glitches, raising concerns over the platform's reliability as it enters a key phase of adding more users.
The eMPF platform, built by a unit of Hong Kong tycoon Richard Li's PCCW Ltd. and Singapore-based subcontractor iFast Corp., showed tech issues including log-in difficulty, according to people familiar with the project, who requested not to be named.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

China's Credit Market Just Did Something It Hasn't in 20 Years -- Here's What It Means for Investors
China's Credit Market Just Did Something It Hasn't in 20 Years -- Here's What It Means for Investors

Yahoo

timean hour ago

  • Yahoo

China's Credit Market Just Did Something It Hasn't in 20 Years -- Here's What It Means for Investors

New loan issuance in China just turned negative for the first time in nearly two decades. According to data released Wednesday by the People's Bank of China, yuan-denominated loans fell by 49.9 billion yuan ($7 billion) in Julystunningly missing the median forecast of a 300 billion yuan increase. This isn't just a soft patch. It's the first monthly contraction since July 2005. The drop wasn't due to tighter policy, but net repayments. Borrowershouseholds and businesses alikeare choosing to pay down debt instead of taking on more, suggesting confidence in future growth is weakening. Government stimulus so far hasn't been enough to reverse that mindset. Warning! GuruFocus has detected 6 Warning Signs with AMD. Behind the headline number is a deeper chill. Short-term consumer credit is collapsing, with households repaying a net 383 billion yuan of short-term loans in the first seven monthssomething we haven't seen since records began in 2009. Medium- and long-term loans, usually more stable, also took a hit in July. Even corporate borrowing turned negative for the first time since 2016. On the surface, aggregate financing rose 1.2 trillion yuan, helped by strong government bond issuance. But even that missed expectations. The broader read: demand for credit isn't just weakit's deteriorating, even as nominal GDP growth hits its lowest post-pandemic level since data collection began in 1993. Policymakers appear cautious, but cracks are widening. Beijing just announced interest subsidies on select consumer loans to nudge borrowers back into action. Still, analysts expect real monetary easing won't kick in until Q4possibly more rate cuts or lower reserve requirements. Until then, the economy looks stuck in a loop of deflation and deleveraging. That's not a great setup for risk assets tied to Chinese consumers. Investors in China-exposed names like Tesla (NASDAQ:TSLA) might want to brace for weaker tailwinds from the mainland, at least for now. This article first appeared on GuruFocus.

ReNew Announces Results for the First Quarter for Fiscal Year 2026 (Q1 FY26), ended June 30, 2025
ReNew Announces Results for the First Quarter for Fiscal Year 2026 (Q1 FY26), ended June 30, 2025

Yahoo

timean hour ago

  • Yahoo

ReNew Announces Results for the First Quarter for Fiscal Year 2026 (Q1 FY26), ended June 30, 2025

43% surge in Adj. EBITDA YoY and 13x increase in PAT; 23% growth in operating MWs YoY GURUGRAM, India, August 13, 2025--(BUSINESS WIRE)--ReNew Energy Global Plc ("ReNew" or "the Company") (Nasdaq: RNW, RNWWW), a leading decarbonization solutions company, today announced its unaudited consolidated IFRS results for the three-month period ended June 30, 2025. Operating Highlights: As of June 30, 2025, the Company's portfolio consisted of ~18.2 GWs (+1.1 GWh BESS), compared to ~15.6 GWs as of June 30, 2024. In addition, the Company has 6.5 GW of solar module manufacturing and 2.5 GW of cell manufacturing which is operational and is building a 4 GW cell manufacturing facility. The Company's commissioned capacity has increased 14.8% year-over-year to ~11.1 GWs (+150 MWh BESS) (net of 600 MWs of assets sold since Q1 FY25) as of June 30, 2025. Subsequently, we commissioned additional 50 MWs in July 2025. Total Income (or total revenue) for Q1 FY26 was INR 41,182 million (US$ 480 million), compared to INR 24,903 million (US$ 290 million) for Q1 FY25. Revenue from sale of power for Q1 FY26 was INR 25,473 million (US$ 297 million), compared to INR 22,335 million (US$ 260 million) for Q1 FY25. Net profit for Q1 FY26 was INR 5,131 million (US$ 60 million) compared to INR 394 million (US$ 5 million) for Q1 FY25. Adjusted EBITDA for Q1 FY26 was INR 27,220 million (US$ 317 million), as against INR 18,979 million (US$ 221 million) in Q1 FY25. Total income (or total revenue) for Q1 FY26 from our module and cell manufacturing operations was INR 13,223 million (US$ 154 million). Net profit and Adjusted EBITDA for Q1 FY26 from external sales from our module and cell manufacturing operations was INR 3,562 million (US$ 42 million) and INR 5,292 million (US$ 62 million) respectively. Note: the translation of Indian rupees into U.S. dollars has been made at INR 85.74 to US$ 1.00. FY26 Guidance The Company reiterates its FY26 guidance and expects to complete the construction of 1.6 to 2.4 GWs by the end of Fiscal Year 2026. The Company's Adjusted EBITDA and Cash Flow to Equity guidance for FY26 are subject to weather and resource availability. The Company anticipates continued net gains in sales of assets, which is part of ReNew's capital recycling strategy, and has included INR 1-2 billion related to asset sales in the Adjusted EBITDA. The Company now expects external sales from our module and cell manufacturing to contribute INR 8-10 billion of Adjusted EBITDA against such sales in this guidance. Financial Year Adjusted EBITDA Cash Flow to equity (CFe) FY26 INR 87 – INR 93 billion INR 14 – INR 17 billion Note: the translation of Indian rupees into U.S. dollars has been made at INR 85.74 to US$ 1.00. Webcast and Conference call information A conference call has been scheduled to discuss the earnings results at 8:30 AM EDT (6:00 PM IST) on August 14, 2025. The conference call can be accessed live at: or by phone (toll-free) by dialing: US/ Canada: (+1) 855 881 1339France: (+33) 0800 981 498Germany: (+49) 0800 182 7617Hong Kong: (+852) 800 966 806India: (+91) 0008 0010 08443Japan: (+81) 005 3116 1281Singapore: (+65) 800 101 2785Sweden: (+46) 020 791 959UK: (+44) 0800 051 8245Rest of the world: (+61) 7 3145 4010 (toll) An audio replay will be available following the call on our investor relations website at Forward Looking Statements This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended and the Private Securities Litigation Reform Act of 1995, including statements regarding our future financial and operating guidance, operational and financial results such as estimates of nominal contracted payments remaining and portfolio run rate, and the assumptions related to the calculation of the foregoing metrics. The risks and uncertainties that could cause our results to differ materially from those expressed or implied by such forward-looking statements include: the availability of additional financing on acceptable terms; changes in the commercial and retail prices of traditional utility generated electricity; changes in tariffs at which long-term PPAs are entered into; changes in policies and regulations including net metering and interconnection limits or caps; the availability of rebates, tax credits and other incentives; the availability of solar panels and other raw materials; our limited operating history, particularly as a relatively new public company; our ability to attract and retain relationships with third parties, including solar partners; our ability to meet the covenants in our debt facilities; meteorological conditions; supply disruptions; solar power curtailments by state electricity authorities and such other risks identified in the registration statements and reports that our Company has filed or furnished with the U.S. Securities and Exchange Commission, or SEC, from time to time. Portfolio represents the aggregate megawatts capacity of solar power plants pursuant to PPAs, signed or allotted or where we have received a letter of award. There is no assurance that we will be able to sign a PPA even though we have received a letter of award. All forward-looking statements in this press release are based on information available to us as of the date hereof, and we assume no obligation to update these forward-looking statements. About ReNew Unless the context otherwise requires, all references in this press release to "we," "us," or "our" refers to ReNew and its subsidiaries. ReNew is a leading decarbonization solutions company listed on Nasdaq (Nasdaq: RNW, RNWWW). ReNew's clean energy portfolio of ~18.2 GW (+1.1 GWh BESS) on a gross basis as of August 13, 2025, is one of the largest globally. In addition to being a major independent power producer in India, we provide end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalisation, storage, and carbon markets that are increasingly integral to addressing climate change. For more information, visit and follow us on LinkedIn, Facebook, Twitter, and Instagram. View source version on Contacts Press Enquiries pr@ Investor Enquiries Anunay Shahi, Nitin Vaid | ir@

The Oncology Institute Announces Changes to Board of Directors
The Oncology Institute Announces Changes to Board of Directors

Yahoo

timean hour ago

  • Yahoo

The Oncology Institute Announces Changes to Board of Directors

Richard Barasch to Retire; Anne McGeorge Brings Extensive Financial Experience to Role as New Chairman CERRITOS, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ('TOI') (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Richard Barasch will retire from his role as Chairman of the Board, effective August 12, 2025. Anne McGeorge, who currently serves as a Board Member and Chair of the Audit Committee, will succeed Barasch in the role. 'We are thrilled to have Anne McGeorge serve as our next Chairman of the Board,' said Daniel Virnich, MD, CEO of The Oncology Institute. 'Having worked with Anne since she joined The Oncology Institute's board in 2021, I feel confident that she is the right person for the job. Her extensive experience in providing strategic guidance to management teams, deep knowledge of the healthcare space and proven financial acumen have been greatly beneficial to The Oncology Institute thus far and we look forward to working even more closely with her as she takes on this leadership role.' Ms. McGeorge brings over 35 years of experience as a trusted operational and financial advisor to healthcare organizations. Before retiring in 2017, she helped launch Grant Thornton LLP's Global Health Care and Life Sciences Practice and served as the managing partner for 10 years, growing it into a $250 million global business during her time in the position. Earlier in her career, she was a partner at both Deloitte and Arthur Andersen and an adjunct professor at the University of North Carolina School of Public Health. Currently, Ms. McGeorge serves on the board of directors and as the chair of the Audit Committee of Dianthus Therapeutics (NASDAQ: DNTH), a clinical-stage biotechnology company, Nimbus Therapeutics and CitiusTech, both privately held healthcare companies, CLEAR Insurance, a Cayman based Captive Insurance Company, and the William and Mary Business School Foundation. She holds an MS degree in Accounting from the University of Virginia and a BBA degree in Accounting from William & Mary. "I am honored to serve as Chairman and look forward to working with the board and management team to continue advancing our mission of providing exceptional oncology care," said Ms. McGeorge. Dr. Virnich added, "We thank Richard for his outstanding leadership and dedication to The Oncology Institute. Under his guidance, we became a publicly traded company, strengthened our management team, and we were able to prove our business model and value to payors outside of California. The leadership that he brought to our Board and the organization as a whole will have a lasting impact.' Mr. Richard Barasch said, 'Having been with The Oncology Institute since it became a public company, I have had the privilege of getting to know this impressive mission-driven organization, so capably led by CEO Dan Virnich. Anne McGeorge is the best candidate to take over my role as Chairman, and I look forward to seeing the contributions she will surely make with her impressive experience and skillset.' About The Oncology Institute Founded in 2007, The Oncology Institute, Inc. (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better. For more information, visit Contacts Media The Oncology Institute, Investors ICR HealthcareTOI@ in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store